This inventor holds 1 USPTO granted patent. Top assignee: Novartis Ag. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Catherine Ann Sabatos-Peyton: Innovator in Antibody Therapies
Introduction
Catherine Ann Sabatos-Peyton is a prominent inventor based in Waban, MA (US). She has made significant contributions to the field of biotechnology, particularly in the development of combination therapies involving antibody molecules.
Latest Patents
Catherine holds a patent titled "Combination Therapies Comprising Antibody Molecules to LAG-3." This innovative work reflects her commitment to advancing therapeutic options in immunology.
Career Highlights
Catherine is associated with Novartis AG, a leading global healthcare company. Her role at Novartis has allowed her to work on groundbreaking research and development projects that aim to improve patient outcomes.
Collaborations
Throughout her career, Catherine has collaborated with esteemed colleagues, including Glenn Dranoff and Frederic Triebel. These partnerships have fostered a collaborative environment that enhances the innovation process.
Conclusion
Catherine Ann Sabatos-Peyton is a trailblazer in the field of antibody therapies, with a focus on combination treatments. Her work continues to influence the landscape of biotechnology and improve therapeutic strategies for patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile